Can a common diabetes drug actually slow aging? Doctors review metformin ...

A common diabetes drug may help slow age-related vision loss, giving researchers a promising new clue for protecting eyesight ...

Weight loss and diabetes drugs such as Mounjaro, Ozempic, and Wegovy are linked to an increased risk of hair loss, ...

A woman reversed her type 2 diabetes after changing her diet, and new research suggests others may achieve remission too.

New study links weight loss jabs to huge drop in alcohol-related hospital admissions - The analysis found GLP-1 drugs slashed ...

Novo says Lilly's TV and social media campaigns cite outdated trial data to make Zepbound and Mounjaro look more effective ...

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers ...

Health insurance covers the high costs of diabetes, such as a hospital stay for a serious complication, but not the daily costs of medicines and tests.

Novo Nordisk sued Eli Lilly, alleging misleading ads unfairly compare doses of Zepbound and Mounjaro with Wegovy and Ozempic.

Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy ...

PvPI urges public for timely reporting of ADRs to strengthen safety monitoring of diabetes drug semaglutide: Shardul Nautiyal, Mumbai Monday, July 20, 2026, 08:00 Hrs [IST] Recogn ...

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...